Dedicated to fostering the development and manufacturing of high-quality biologic drugs, vaccines, stem cells, and regenerative medicines in Taiwan for the global market, Biologics World Taiwan 2025 is poised to continue its impactful legacy.
This year's conference will delve into a spectrum of pivotal topics, including must-see innovations originating from Taiwan, best practices in clinical research and trials, optimization of upstream processing, cost reduction in downstream processes, advancements in CAR-T and stem cell therapy, compelling case studies in regenerative medicines, and more. The agenda promises the most comprehensive coverage of Taiwan's biologics development and manufacturing landscape.
By participating in the conference, attendees will have the opportunity to engage with key and emerging entities within Taiwan's Biologics and Vaccine space, including distinguished organizations such as PharmaEssentia, Eirgenix, Mycenax, Medigen Biotechnology Corp, Lumosa Therapeutics, and others. If Taiwan stands out as a region rich in opportunities within the bio-manufacturing, vaccine, and cell therapy sectors, then Biologics World Taiwan 2025 is the definitive event to attend.
Discover the latest developments in Taiwan's biologics manufacturing sector, spanning from current best R&D practices to the trajectory towards advanced manufacturing. Immerse yourself in recent, exclusive case studies and gain insights into the industry's key needs—all under one roof! Don't miss this opportunity to stay at the forefront of Taiwan's dynamic biologics landscape.
